Philadelphia Chromosome Negative Chronic Myelogenous Leukemia
3 clinical trials · Condition
◉ Watch Philadelphia Chromosome Negative Chronic Myelogenous Leukemia
| Record | Firm | Date |
|---|---|---|
| Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies (NCT01427881) | Fred Hutchinson Cancer Center | 2011-09-01 |
| 3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia (NCT00381550) | National Cancer Institute (NCI) | 2006-08-01 |
| Vorinostat and Decitabine in Treating Patients With Relapsed, Refractory, or Poor-Prognosis Hematologic Cancer or Other Diseases (NCT00357708) | National Cancer Institute (NCI) | 2006-06-01 |
Track Philadelphia Chromosome Negative Chronic Myelogenous Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.